IPIC Message Board - Msg: 7216894

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rambi who wrote (1292)	1/11/1999 1:51:00 PM
From: Cacaito	Read Replies (1) of 1359

The Lancent has study of buciprolol (not IPIC's bucindolol) for heart failure patients. This is a confirmation of the use of betablockers for congestive heart failure. IPIC bucindolol program is at least one of the contenders for that market (also carvedilol is in the race). This is not why the price is up, but remember ITRC went up inmediately after the new year holiday.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next